Clarity

Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease

Retrieved on: 
Tuesday, May 16, 2023
Priority review, The New England Journal of Medicine, Plaque, NDS, MHLW, Marketing, Neurotoxicity, Food, Advisory Committee, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, Lecanemab, BIIB, Ministry of Health, Labour and Welfare, Brain, Pharmaceuticals and Medical Devices Agency, Medication, Oncology Drug Advisory Committee, EMA, Clarity, Ministry, The Different Forms of Flowers on Plants of the Same Species, Eisai, Prescription Drug User Fee Act, Headquarters, PMDA, National Medical Products Administration, Corporation, Co-promotion, PDUFA, Ministry of Health (Kuwait), MAA, AD, FDA, Phase, Health Canada, BLA, NMPA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disease, Pharmaceutical industry, Biogen, Health

Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.

Key Points: 
  • Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.
  • As such, lecanemab may have the potential to have an effect on disease pathology and to slow down the progression of the disease.
  • The Clarity AD study of lecanemab met its primary endpoint and all key secondary endpoints with highly statistically significant results.
  • Lecanemab was approved under the accelerated approval pathway in the U.S. and was launched in the U.S. on January 18, 2023.

Clarity AI: Only 4% of “Sustainable” Investment Funds Would Automatically Comply with Requirements of US, UK and EU Regulatory Investment Fund Label and Naming Rules

Retrieved on: 
Monday, May 15, 2023
Legal, Software, Data Analytics, Finance, Environmental, Social and Governance (ESG), Banking, Professional Services, Technology, Forest Products Research Laboratory, European Securities and Markets Authority, Article, Innovation, Clarity, Article 8 of the European Convention on Human Rights, Name, Investment, SFDR, Confusion, ESG, ESMA, Eets, Cryptocurrency, Medical device, Security (finance), EU

Clarity AI , the leading sustainability tech platform, released a new analysis on funds with sustainability or ESG-related terms in their name.

Key Points: 
  • Clarity AI , the leading sustainability tech platform, released a new analysis on funds with sustainability or ESG-related terms in their name.
  • The report found that regulatory regimes for sustainability disclosures and labels differ significantly across the US, UK and EU, leaving both issuers and investors confused.
  • 80% of the assets it invests in are used to meet the ESG-related characteristics that it promotes (i.e.
  • However, understanding the challenges and pitfalls of cross-border regulations is essential to combat limited regulatory alignment.

Clarity AI and GIST Impact Team Up to Launch Market-Leading Biodiversity Assessment and Reporting Capabilities

Retrieved on: 
Tuesday, May 9, 2023
Professional Services, Data Management, Data Analytics, Environment, Technology, Sustainability, Software, GIST, Partnership, Task force, Risk management, Intelligence, Clarity, Biodiversity, SFDR, Knowledge, Agriculture

Leading sustainability technology platform, Clarity AI , and leading impact data and intelligence provider, GIST Impact, have announced their latest partnership in the development of a biodiversity impact assessment product.

Key Points: 
  • Leading sustainability technology platform, Clarity AI , and leading impact data and intelligence provider, GIST Impact, have announced their latest partnership in the development of a biodiversity impact assessment product.
  • We’re excited to partner with Clarity AI, combining their deep technology expertise with our industry-leading biodiversity impact methodology and data.
  • Together we’re providing access to credible biodiversity data that is company-specific, geographically accurate, and provides the most holistic coverage of biodiversity impact drivers.
  • "Partnering with GIST Impact is a significant step for Clarity AI as it enables us to leverage their extensive experience, knowledge, platforms and data on biodiversity impact assessments.

Clarity AI Hosts Inaugural Customer Advisory Board Meeting with Institutional Investors

Retrieved on: 
Friday, May 5, 2023
Technology, Mobile, Wireless, Other Professional Services, Legal, Insurance, Consulting, Banking, Professional Services, Artificial Intelligence, Environment, Other Technology, Sustainability, Data Management, Consumer Electronics, MetLife, PGIM, Customer advisory council, Innovation, Clarity, Biodiversity, Invesco, ESG, Strategic sustainable investing, Medical device

Clarity AI, the leading sustainability tech platform, recently held its inaugural Customer Advisory Board Meeting for investment managers.

Key Points: 
  • Clarity AI, the leading sustainability tech platform, recently held its inaugural Customer Advisory Board Meeting for investment managers.
  • "The inaugural Customer Advisory Board Meeting was a great success," said Lorenzo Saa, Chief Sustainability Officer at Clarity AI.
  • The event was a significant milestone for Clarity AI, as it showcased the company's commitment to working with industry players to drive progress towards sustainability.
  • The meeting provided a forum for investment managers to share their experiences and challenges, and to work collaboratively with Clarity AI to develop solutions.

Diligent Launches Board Reporting for ESG, Providing Directors With Clear and Consistent Insight Into Climate Performance Amid CSRD and Upcoming SEC Climate Disclosure Requirements

Retrieved on: 
Tuesday, May 2, 2023
Technology, Human Resources, Professional Services, Business, Software, Networks, Data Management, Environmental, Social and Governance (ESG), Artificial Intelligence, Other Professional Services, Software as a service, S&P Global, GRC, Perception, Data collection, Privacy and Civil Liberties Oversight Board report on mass surveillance, Carbon, Clarity, Risk, Knowledge, ESG, Cirrus Logic, C40 Cities Climate Leadership Group, Guidewire Software, Management, Diligence

Built on the only platform that offers tools to support an organization through its entire GRC journey, Board Reporting for ESG can be tailored to capture an organization’s climate and other ESG data.

Key Points: 
  • Built on the only platform that offers tools to support an organization through its entire GRC journey, Board Reporting for ESG can be tailored to capture an organization’s climate and other ESG data.
  • This enables sustainability professionals to focus on the data that matters, delivering reporting in an easy-to-comprehend format for executive management and company directors.
  • Board-ready reporting dashboards designed to provide insight into the relationship between company performance and stakeholder perception on sustainability and ESG.
  • To learn more about how Diligent can help your organization streamline board-level reporting on ESG and across your business, visit Diligent’s Board Reporting Toolkit.

Freddie Mac Clarity Data Intelligence Enhanced with MBS Portal

Retrieved on: 
Monday, May 1, 2023
Transfer, Housing, MBS, Senior, FMCC, Consumer, OTCQB, The New Daily, Clarity, Home Affordable Refinance Program, Freddie Mac, CRT, Cryptocurrency, Financial services, Cohort

MCLEAN, Va., May 01, 2023 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today announced enhanced access to Mortgage-Backed Securities (MBS) analytics data through its Clarity Data Intelligence® (Clarity) tool.

Key Points: 
  • MCLEAN, Va., May 01, 2023 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today announced enhanced access to Mortgage-Backed Securities (MBS) analytics data through its Clarity Data Intelligence® (Clarity) tool.
  • “With Clarity, Freddie Mac MBS investors now have easy, efficient access to critical performance data through the same centralized hub our Credit Risk Transfer (CRT) investors have enjoyed for years,” said Mark Hanson, Senior Vice President for Securitization at Freddie Mac.
  • Clarity account holders have the option to choose between CRT or MBS portals.
  • Key data on the MBS portal includes:
    The New Daily Prepayment Report, with Cumulative Daily Voluntary Payoffs by Cohort;
    Affordable and Green MBS Issuance Volume; and
    Investors with questions about the MBS portal or Freddie Mac’s mortgaged-backed securities can contact Freddie Mac Investor Relations at [email protected].

TechSmith Announces Best-selling Author Adam “Smiley” Poswolsky Will Keynote Its Level Up Digital Event on Improving Workplace Communication

Retrieved on: 
Monday, May 1, 2023
EDU, Communication, Education, Culture, Workplace, Work, EDT, Asynchrony, Clarity, Connection, Hybrid, Prince Harry, Duke of Sussex, Environment, Handshake, Management, Sales, Gallup

As hybrid work has become the norm, and time spent face-to-face has been replaced with wall-to-wall Zoom meetings and 24/7 Slack messages, workplace connection has withered.

Key Points: 
  • As hybrid work has become the norm, and time spent face-to-face has been replaced with wall-to-wall Zoom meetings and 24/7 Slack messages, workplace connection has withered.
  • According to Gallup , 70% of employees are disengaged from their jobs and 20% are actively disengaged.
  • “Relationship building in the workplace is the next challenge that we must tackle now that the pandemic is behind us,” said Poswolsky.
  • As hybrid and remote work becomes more common, effective communication across teams and departments is more vital now, than ever.

Creative Realities Partners with Freshëns to Revolutionize the Digital Menu Board Experience Utilizing Clarity™ Software Platform

Retrieved on: 
Thursday, April 27, 2023
Heart, Partnership, Food, University, Airport, George Mason University, Clarity, State, FLIP, CREX, Digital, Software, Online shopping, Restaurant

The new menu board experience features a streamlined process for real-time menu board updates.

Key Points: 
  • The new menu board experience features a streamlined process for real-time menu board updates.
  • “Freshëns wanted to create a digital menu board solution that would align with their commitment to healthy and fresh food and stands out from traditional menu boards that can be disorganized and overwhelming,” said Rick Mills, CEO at Creative Realities.
  • Most recently, Freshëns utilized Creative Realities' digital expertise to enhance customer experiences at their newest FLIP Kitchen location on the campus of George Mason University.
  • “We're thrilled to team up with Creative Realities and take our digital menu boards to the next level," said John Stern, Freshëns CEO.

Clarity AI Virtual Event Reveals 52% of Consumers Believe Sustainability Information about Their Purchases is a Must-have

Retrieved on: 
Tuesday, April 4, 2023
Other Consumer, Fashion, Manufacturing, Cosmetics, Environment, Retail, Artificial Intelligence, Sustainability, Software, Finance, Environmental Issues, Online Retail, Consumer, Professional Services, Data Management, Technology, Packaging, Engineering, Chemicals, Plastics, Food, Prostitution in the Dutch Caribbean, AT, Electronics, EBay, Carbon, Target, Estée Lauder, Clarity, Citigroup, Danone, Procter & Gamble, Machine learning, Panasonic, Wayfair, Kimberly-Clark, Online shopping, Bridgestone, Amazon

Clarity AI , the leading sustainability technology platform, hosted a virtual event on March 28, 2023, that brought together over 900 registrants from the world's leading consumer brands and ecommerce platforms.

Key Points: 
  • Clarity AI , the leading sustainability technology platform, hosted a virtual event on March 28, 2023, that brought together over 900 registrants from the world's leading consumer brands and ecommerce platforms.
  • The event featured executive speakers from Klarna, Clarity AI, Greenbiz, and Lyst, who discussed a range of topics related to sustainability in consumer products.
  • It also included a survey of attendees, which revealed insights about consumer attitudes towards sustainability.
  • Over half of the survey respondents (52%) said that they believe their customers consider sustainability information to be a must-have when making purchasing decisions.

Long-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published

Retrieved on: 
Tuesday, April 4, 2023
Priority review, Plaque, CET, MHLW, Marketing, Advisory Committee, Memantine, Food, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, Lecanemab, Clinical trial, Quality of life, Ministry of Health, Labour and Welfare, Brain, Alzheimer's disease, SOC, MCI, Medication, Pharmaceuticals and Medical Devices Agency, Advisory Committee on Immunization Practices, EMA, Clarity, Ministry, Eisai, Prescription Drug User Fee Act, HIV disease progression rates, Patient, Standard of care, PMDA, National Medical Products Administration, Co-promotion, PDUFA, Ministry of Health (Kuwait), Neurology, MAA, AD, FDA, BLA, NMPA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disease, Caregiver, Safety, Pharmaceutical industry, Biogen, Health

A subgroup analysis suggested that earlier initiation of treatment with lecanemab may have a greater impact on disease progression.

Key Points: 
  • A subgroup analysis suggested that earlier initiation of treatment with lecanemab may have a greater impact on disease progression.
  • This paper has been revised to incorporate data from the Phase 3 Clarity AD clinical trial, replacing the previous simulation of long-term health outcomes which relied on results from the Phase 2b clinical trial, published in April 2022.
  • The analysis is based on a disease simulation model (AD ACE model[3]) that used data from the Phase 3 Clarity AD clinical trial, which evaluated the efficacy and safety of lecanemab, and published literature to simulate the natural progression of AD.
  • The U.S. Food and Drug Administration (FDA) determined that the results of Clarity AD can serve as the confirmatory study to verify the clinical benefit of lecanemab.